NewsBenzinga巴克莱启动利健制药的覆盖,给予超重评级,宣布目标股价为345美元 巴克莱启动利健制药的覆盖,给予超重评级,宣布目标股价为345美元 Benzinga 2026.09.25 12:30 (GMT+0) Open on Benzinga Other news Wells Fargo Initiates Coverage On Hubbell with Equal-Weight Rating, Announces Price Target of $531 What's Happening With D-Wave Quantum Stock Friday? Wells Fargo Initiates Coverage On Honeywell Intl with Equal-Weight Rating, Announces Price Target of $231 HSBC Upgrades Synopsys to Buy, Raises Price Target to $700 Morgan Stanley Maintains Equal-Weight on T. Rowe Price Group, Lowers Price Target to $110 HSBC Maintains Buy on Chevron, Raises Price Target to $250
Wells Fargo Initiates Coverage On Honeywell Intl with Equal-Weight Rating, Announces Price Target of $231